Jasper Therapeutics, Inc. (JSPR)
Latest JSPR Insider Trades
Matthew E. Ros - OfficerOpen-market purchase881 sh- Patrick J. Crutcher - DirectorOpen-market purchase888 sh
About Jasper Therapeutics, Inc. (JSPR)
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
- REDWOOD CITY, CA
- 22
- 2021
- XNAS
https://www.jaspertherapeutics.comSEC filings for JSPR on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 1,769 | - |
| Grant or award | 6 | 52,500 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
JSPR Insider Transactions (Form 4)
3225 Form 4 filings on record, the earliest from Dec 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas G. Wiggans - Director | Grant or award | Stock Option (Right to Buy |
Recent JSPR Form 8-K Filings
5JSPR Insider Trading - FAQ
What is the latest insider trade for JSPR?
Jasper Therapeutics, Inc. (JSPR) had 7 insider filings in the last 90 days, with the most recent on 2026-08-04. The full record for JSPR runs to 25 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying JSPR stock?
2 insider purchases of JSPR were filed in the last 90 days.
How many insiders are selling JSPR stock?
No insider sales of JSPR were filed in the last 90 days. 1 sale is on record for this company.
Where can I see JSPR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks JSPR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow JSPR insider buys?
Create a free InsiderAlpha account and press Watch on this page to add JSPR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Thomas G. Wiggans view on EDGAR
- - Svetlana Lucas view on EDGAR
- - Patrick J. Crutcher view on EDGAR
- - Kurt von Emster view on EDGAR
- - Judith Anne Shizuru view on EDGAR
- - Matthew E. Ros view on EDGAR
- - Patrick J. Crutcher view on EDGAR
- - Jeetinder Singh Mahal view on EDGAR
- - Ron Martell view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where JSPR's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track JSPR insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
